Aker BioMarine ASA (OSL:AKBM)

Market Cap	9.79B +61.7%
Revenue (ttm)	2.20B +9.6%
Net Income	-229.84M
EPS	n/a
Shares Out	87.70M
PE Ratio	n/a
Forward PE	42.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,483
Average Volume	20,129
Open	113.00
Previous Close	109.80
Day's Range	106.80 - 113.00
52-Week Range	43.65 - 115.00
Beta	0.37
RSI	65.76
Earnings Date	Mar 26, 2026

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 249
• Stock Exchange: Oslo Børs
• Ticker Symbol: AKBM

Financial Performance

Financial numbers in USD